Rhonda J. Robb has bought CSII on 3 days since Aug 2020

Rhonda J. Robb is a corporate executive and board director in the medical device industry, best known for her tenure as Chief Operating Officer at Cardiovascular Systems Inc. (CSII), where she also serves as a corporate insider through her ownership and trading of CSII stock.( As COO, a role she held from January 2018 through 2022, Robb oversaw operations at the New Brighton, Minnesota–based company focused on interventional treatment systems for peripheral and coronary artery disease, reporting directly to the Chairman, President, and CEO.( Her insider filings show multiple equity acquisitions in CSII, including trades in 2022, reflecting her alignment with shareholders and executive accountability.(

Robb brings more than 25–30 years of leadership experience in cardiovascular and cardiac rhythm medical technologies, largely built at Medtronic, where she held senior roles including Vice President and General Manager of Heart Valve Therapies, leading both transcatheter and surgical valve franchises, as well as prior leadership positions in coronary, peripheral, and cardiac rhythm businesses.( She later advanced to President and Chief Executive Officer of Okami Medical Inc., a company focused on peripheral vascular interventions, and serves on boards such as the American Heart Association and 4C Medical.( Robb holds a bachelor’s degree from the University of Minnesota and an MBA from the Carlson School of Management at the University of Minnesota, grounding her executive career in both technical market expertise and formal business training.(

Written by Perplexity from public sources.